Virksomhedsform
Aktieselskab
Etableret
2003
Størrelse
Små
Ansatte
11
Omsætning
569 MDKK
Bruttofortj.
23 MDKK
Primært resultat (EBIT)
14 MDKK
Årets resultat
31 MDKK
Egenkapital
139 MDKK
annonce

Flere nøgletal og analyser?

Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!

Rang Årets resultat

Rang i branche
11/526
"Top 10%"
Rang i Danmark
3.344/343.166
"Top 10%"

Bestyrelse top 3

Steen Meldgaard Astrup 2Bestyrelsesformand
Christoph Schrader 1Bestyrelsesmedlem
Mads Christian Olesen 18Bestyrelsesmedlem

Legale ejere top 3

66.67-89.99%Chr. Olesen A/S
5-9.99%Ignacio de Rojas

Tegningsregler

Selskabet tegnes af en direktør eller et bestyrelsesmedlem eller af den samlede bestyrelse.

Stamoplysninger baseret på CVR

NavnChr. Olesen Nutrition A/S
CVR27270883
AdresseJægersborg Alle 164, 2820 Gentofte
BrancheAnden specialiseret engroshandel i.a.n. [468900]
Etableret30-06-2003 (21 år)
Første regnskabsperiode30-06-2003 til 30-09-2004
VirksomhedsformAktieselskab
Antal ansatte4 (årsværk:3)
ReklamebeskyttelseNej
RevisorPricewaterhousecoopers Statsautoriseret Revisionspartnerselskab siden 01-07-2011
Regnskabsperiode01-10 til 30-09
BankforbindelseSydbank
Selskabskapital537.500 DKK
500.000 DKK (30-06-2003 - 29-09-2022)
Vedtægter seneste30-09-2022

Medlem af brancherne

Formål

Selskabets formål er at drive handel med og distribution af fine chemicals til pharma- og fødevareindustrien.

Regnskab

 202320222021
Valuta/enhed000' DKK000' DKK000' DKK
Omsætning
568.674
-2%
579.693
+54%
377.429
+22%
Bruttofortjeneste
23.249
-41%
39.324
+174%
14.340
-27%
Årets resultat
30.645
-48%
58.609
+127%
25.777
+15%
Egenkapital
138.591
+8%
128.148
+113%
60.228
-22%
Balance
420.183
-14%
486.088
+89%
257.063
+29%

Ledelsesberetning sammendrag

Ledelsesberetning
Key activities Chr. Olesen Nutrition A/S is a part of the Chr. Olesen Group.Chr. Olesen Group was established in 1885 and is now represented by the 4th and 5th generation. The Company has grown to a multinational group during the 4th generation.Chr. Olesen Group is operating within international distribution of ingredients and additives for animal feed (FEED), ingredients and additives for human use (FOOD) and pharmaceutical products (PHARMA) for humans and for animals (ACTIVET) and, from 2023, also with ingredients for the technical industry – including minerals (INDUSTRIAL).Along with the trading of products (purchase and sale), the Chr. Olesen Group is highly specialised in the services required to deliver the products – ie shipping, inventory management, financing, insurance, bookkeeping and quality management.Chr. Olesen Nutrition A/S is a subsidiary within the Chr. Olesen Group. The company covers distribution of Food ingredients to Europe. The company has no direct employees, but is part of the costs in Chr. Olesen A/S. Development in the year The income statement of the Company for 2022/23 shows a profit of EUR 4,107,575, and at 30 September 2023 the balance sheet of the Company shows positive equity of EUR 18,576,161. The past year and follow-up on development expectations from last year Revenue for the year is above expected levels. The company have experienced progress in relation to expectationsManagement considers the results to be satisfactory. Capital resources The credit facilities of the Chr. Olesen Group are renegotiated every year in January/February. Credit facilities for the Chr. Olesen Group are expected to be negotiated to the same level as last year. Foreign exchange risks Significant parts of the Group’s transactions take place in foreign currencies. As an element in the Group’s business strategy, Management has determined that day-to-day foreign currency exposures should be hedged by entering into forward exchange contracts, periodical borrowing or placement of funds in foreign currencies. Moreover, currency options are also used for hedging purposes. Targets and expectations for the year ahead Chr. Olesen Group will continue the strategy of growing and consolidating all of its companies - including developing Chr. Olesen Nutrition A/S in the long-term perspective.In the coming year, same as last year, special emphasis will be placed on further upgrading of the the organisation's communication about safety (safety culture).Management expects a financial year with revenue equivalent compared to last year despite intensifying competition. Subsequent events No events materially affecting the assessment of the Annual Report have occurred after the balance sheet date.
Generalforsamlingsdato: 01-02-2024

Kort